{"$schema": "https://iptc.org/std/ninjs/ninjs-schema_3.2.json", "uri": "urn:newsml:wireva.mib.news:story:c148c2e7-e55c-417b-9dfe-7a2a87018a14", "type": "composite", "version": "1", "versioncreated": "2026-08-26T19:03:00.209558Z", "firstcreated": "2026-08-26T19:03:00.209558Z", "pubstatus": "usable", "language": "en", "headline": "FDA grants expedited approval to first pill targeting mutated protein in pancreatic cancer", "description_text": "The US Food and Drug Administration has approved daraxonrasib, a first-of-a-kind oral drug that blocks a mutated protein driving tumor growth in more than 90% of pancreatic cancer cases, offering patients a new treatment option against one of the deadliest cancers.", "associations": {"item-0": {"$schema": "https://iptc.org/std/ninjs/ninjs-schema_3.2.json", "uri": "urn:newsml:wireva.mib.news:item:0200bd3b-d239-4377-8e1a-d1e21e42cfa4", "type": "text", "profile": "standard", "version": "1", "versioncreated": "2026-08-26T19:03:34.257727Z", "firstcreated": "2026-08-26T19:03:00.209558Z", "pubstatus": "usable", "urgency": 5, "language": "en", "headline": "FDA grants expedited approval to first pill targeting mutated protein in pancreatic cancer", "byline": "Jordan Quincy", "located": "United States", "copyrightholder": "Haydamax OÜ", "copyrightnotice": "Wireva / Science Official", "usageterms": "Monitoring item. Headline, short extract and the source link may be shown. Do not republish the full text.", "description_text": "The US Food and Drug Administration has approved daraxonrasib, a first-of-a-kind oral drug that blocks a mutated protein driving tumor growth in more than 90% of pancreatic cancer cases, offering patients a new treatment option against one of the deadliest cancers.", "altids": {"mosaic": "0200bd3b-d239-4377-8e1a-d1e21e42cfa4", "story": "c148c2e7-e55c-417b-9dfe-7a2a87018a14", "slug": "fda-grants-expedited-approval-to-first-pill-targeting-mutated-protein-in-pancreatic-cancer"}, "subject": [{"name": "Health", "rel": "direct", "literal": "health", "code": "medtop:07000000", "scheme": "http://cv.iptc.org/newscodes/mediatopic/", "uri": "http://cv.iptc.org/newscodes/mediatopic/07000000"}], "place": [{"name": "United States", "literal": "us", "code": "US", "scheme": "http://cv.iptc.org/newscodes/countrycodes/"}], "person": [], "organisation": [], "genre": [{"name": "Standard story", "literal": "standard"}], "service": [{"name": "Wireva", "literal": "wireva"}], "body_text": "The US Food and Drug Administration has approved daraxonrasib, a first-of-a-kind oral drug that blocks a mutated protein driving tumor growth in more than 90% of pancreatic cancer cases, offering patients a new treatment option against one of the deadliest cancers.", "extra_body_note": "Extract only — see rights.class = link_only.", "associations": {"featuremedia": {"uri": "urn:newsml:wireva.mib.news:media:46fdfc8e-2bf1-4ee3-9b8d-ee03c9b22cd0", "type": "picture", "version": "1", "pubstatus": "usable", "headline": "FDA gives expedited approval to new groundbreaking pancreatic cancer drug", "description_text": "FDA grants expedited approval to first pill targeting mutated protein in pancreatic cancer", "copyrightholder": "commons.wikimedia.org", "copyrightnotice": "The U.S. Food and Drug Administration", "usageterms": "Public domain work (government or dedicated). Credit appreciated, not required.", "altids": {"wireva": "46fdfc8e-2bf1-4ee3-9b8d-ee03c9b22cd0"}, "extra": {"wireva:delivery_mode": "file", "wireva:rights": {"licence": "Public domain", "licence_url": "https://creativecommons.org/publicdomain/mark/1.0/", "licence_raw": "Public domain", "licence_verified_at": "2026-08-26T19:03:34.270375Z", "attribution_required": false, "attribution_text": "The U.S. Food and Drug Administration", "redistribution_allowed": true, "commercial_use_allowed": true, "modifications_allowed": true, "share_alike_required": false}, "wireva:provenance": {"creator": "", "source_name": "commons.wikimedia.org", "source_url": "https://commons.wikimedia.org/wiki/File:FDA_Unit_Mobilizes_for_Emergency_Response_-_Emergency_Operations_Center_(EOC)_(6992808772).jpg", "source_page_url": "https://commons.wikimedia.org/wiki/File:FDA_Unit_Mobilizes_for_Emergency_Response_-_Emergency_Operations_Center_(EOC)_(6992808772).jpg", "our_page_url": "https://scienceofficial.org/medicine/fda-grants-expedited-approval-to-first-pill-targeting-mutated-protein-in-pancreatic-cancer/"}, "wireva:role": "lead"}, "renditions": {"original": {"href": "https://nbg1.your-objectstorage.com/ckln/image-assets/994f01f405ec33d700a102a6414be52211fb92f250d0061ec61559ddf199f68d.jpg", "mimetype": "image/jpeg", "width": 1350, "height": 900, "sizeinbytes": 202383}, "source": {"href": "https://commons.wikimedia.org/wiki/File:FDA_Unit_Mobilizes_for_Emergency_Response_-_Emergency_Operations_Center_(EOC)_(6992808772).jpg", "mimetype": "image/jpeg"}}}}, "extra": {"wireva:story": {"uri": "urn:newsml:wireva.mib.news:story:c148c2e7-e55c-417b-9dfe-7a2a87018a14", "slug": "fda-grants-expedited-approval-to-first-pill-targeting-mutated-protein-in-pancreatic-cancer-20260826", "status": "developing", "languages": ["en"], "item_count": 1, "is_breaking": false}, "wireva:rights": {"class": "link_only", "redistribution_allowed": false, "commercial_use_allowed": false, "modifications_allowed": true, "share_alike_required": false, "attribution_required": true, "attribution_text": "Wireva / Science Official", "canonical_required": true, "canonical_url": "https://scienceofficial.org/medicine/fda-grants-expedited-approval-to-first-pill-targeting-mutated-protein-in-pancreatic-cancer/", "linkback_required": true, "licence": "", "licence_url": "", "licensor": "Haydamax OÜ", "valid_until": null, "excerpt_max_chars": 280, "decided_by_rule": "derivation_failed", "needs_review": true}, "wireva:provenance": {"production_method": "automated", "ai_stages": {"editing": true, "drafting": true, "headline": true, "discovery": true, "classification": true, "image_selection": true, "source_collection": true, "cross_source_comparison": true}, "model": "", "human_reviewed": false, "reviewed_by": "", "reviewed_at": null, "editorial_control": true, "editorial_responsibility": "Haydamax OÜ (Wireva)", "factchecked": false, "verification_status": "single_source", "independent_confirmations": 0, "official_source_used": false, "used_press_release": false, "public_interest": true, "ai_disclosure_required": true, "ai_disclosure_text": "This item was produced with AI assistance under the editorial responsibility of Haydamax OÜ.", "independence_check": {"status": "failed", "score": 0.696, "checked_at": "2026-08-26T19:03:34.267824Z"}, "sources": [{"url": "https://www.theguardian.com/us-news/2026/aug/26/fda-approves-new-pancreatic-cancer-drug", "title": "FDA gives expedited approval to new groundbreaking pancreatic cancer drug", "publisher": "theguardian.com", "type": "rss", "role": "primary", "official": false, "retrieved_at": "2026-08-26T19:03:34.260890Z", "published_at": "2026-08-26T15:48:27Z"}, {"url": "https://www.theguardian.com/us-news/2026/aug/26/trump-epa-datacenter-forever-chemicals", "title": "", "publisher": "theguardian.com", "type": "rss", "role": "supporting", "official": false, "retrieved_at": "2026-08-26T19:03:34.261465Z", "published_at": null}]}, "wireva:publication": {"name": "Science Official", "domain": "scienceofficial.org", "country": "US", "url": "https://scienceofficial.org/medicine/fda-grants-expedited-approval-to-first-pill-targeting-mutated-protein-in-pancreatic-cancer/"}, "wireva:links": {"self": "https://wireva.mib.news/api/v1/items/0200bd3b-d239-4377-8e1a-d1e21e42cfa4", "html": "https://wireva.mib.news/item/0200bd3b-d239-4377-8e1a-d1e21e42cfa4/fda-grants-expedited-approval-to-first-pill-targeting-mutated-protein-in-pancreatic-cancer/", "story": "https://wireva.mib.news/story/fda-grants-expedited-approval-to-first-pill-targeting-mutated-protein-in-pancreatic-cancer-20260826/"}, "wireva:metrics": {"word_count": 469, "char_count": 3161, "reading_time_seconds": 226}}}}, "extra": {"wireva:languages": ["en"], "wireva:status": "developing", "wireva:item_count": 1}}